4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000905718-17-000626
Director sold 32,368 shares at an average $16.23 ($525,302)
From the SEC's structured data for this filing
Trades in this filing
EMSTER KURT VON · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-06-22 | Sale : show line 1 in the form | −1,527 | $16.21 | $24,753 | 2,600,287 | I |
| 2017-06-23 | Sale : show line 2 in the form | −30,841 | $16.23 | $500,549 | 2,569,446 | I |
| Open-market sales · 32,368 sh · avg $16.23 · $525,302 | ||||||
Loading xslF345X03/vonemster_form4jun222017.xml…